Background

Cardiovascular disease is the most common cause of death in the western world today and at the same time there are no good artificial revascularisation treatments for vessels below five millimetres in internal diameter. Arterion aims to bring a solution.

Further reading about our bacterial cellulose and medical device development can be found here.

The research behind Arterion's technology started around year 2000 as a PhD project at the Biopolymer Department, Chalmers University of Technology. The potential in microbially derived cellulose as a biomaterial stood clear and the research focused towards artificial blood vessels because of the large need in that field.

A collaboration between Chalmers and the Vascular Engineering Center at Göteborg University and Sahlgrenska University Hospital took form around 2003 and then the clinical potential was examined.

In 2006 the commercial potential was properly investigated while the research project entered the Göteborg International Bioscience Business School (GIBBS).